REN and cardiac hypertrophy: In the course of disease progression, myocardial hypertrophy, fibrosis, and remodeling are involved, and a key mediator of this process is the activation of neurohormones, including regulators such as the renin–angiotensin–aldosterone system (Kitsios and Zintzaras 2007).